DCIS中的微环境及其在疾病进展中的作用
Mohammad Reza Roozitalab1, Niki Prekete1, Michael Allen1
1Centre for Tumour Biology, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of London, London, UK.
Advances in experimental medicine and biology
|January 17, 2025
概括
管道癌 in situ (DCIS) 的进展很难预测. 研究强调瘤微环境,而不仅仅是癌细胞,作为了解哪些DCIS病变可能成为侵入性乳腺癌的关键.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 瘤微环境研究 研究
背景情况:
- 管道癌 in situ (DCIS) 是一种常见的乳腺癌前体,但预测进发性乳腺癌 (IBC) 的进展仍然具有挑战性.
- 对上皮细胞的分子分析没有产生DCIS进展的一致预测因素.
- 瘤微环境 (ME) 越来越被认为是DCIS行为中的关键因素.
研究的目的:
- 研究瘤微环境在DCIS进展中的作用.
- 了解肌皮细胞和癌症相关纤维细胞 (CAF) 的变化如何影响DCIS行为.
- 探索DCIS微环境中的异质性及其对疾病结果的影响.
主要方法:
- 审查关于DCIS及其微环境的现有文献.
- 分析DCIS微环境中的细胞和细胞外矩阵变化.
- 专注于DCIS上皮细胞与周围结构和免疫组件之间的相互作用.
主要成果:
- 在DCIS中的肌皮细胞可以从瘤抑制剂转变为侵袭促进剂.
- 与癌症相关的纤维细胞 (CAFs) 重塑细胞外基质并影响信号通路.
- 在CAF,免疫细胞和其他结构元件中存在异质性,影响DCIS行为.
结论:
- 瘤微环境在确定DCIS进展潜力方面发挥着至关重要的作用.
- 了解DCIS微环境中的复杂相互作用对于预测临床结果至关重要.
- 需要进一步进行体外,体内和组织研究,以确定DCIS行为的预测特征.
更多相关视频
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
8.7K
10:55Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
Published on: January 8, 2018
11.0K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
